Elizabeth Kinter is an experienced biotech executive specializing in market access, pricing, and health economics. They held various leadership roles at Biogen from 2020 to 2022, including Executive Director of US Market Access Strategy and Senior Director of Value and Access for Neurodegeneration. Most recently, Elizabeth serves as Vice President and Head of Global Market Access at Avidity Biosciences, Inc., a position they began in 2025. Elizabeth earned their PhD in Health Economics from The Johns Hopkins University, focusing on patient preferences for the medical treatments of schizophrenia, and holds a BA in Economics and German Literature from Smith College.
This person is not in any teams
This person is not in any offices